Table 3:
LncRNAs dysregulated by polycyclic aromatic hydrocarbons and their metabolites exposures.
| Carcinogens | LncRNAs | Cancers | Models | Upstream genes | Downstream genes | Phenotype | References |
|---|---|---|---|---|---|---|---|
| Anti-BPDE | AF118081 (↑) | Lung cancer | Human 16HBE cells, lung cancer cell lines, mice, human lung cancer tissues | – | – | Promote cell proliferation, migration and invasion, promote tumorigenesis in vivo | [87] |
| Anti-BPDE | LOC728228 (↑) | Lung cancer | Human 16HBE cells, lung cancer cell lines, mice | – | CCND1 | Promote G1/S transition, cell proliferation and migration, promote tumorigenesis in vivo | [88] |
| B[a]P | LncRNA-DQ786227 (↑) | Lung cancer | Human BEAS-2B cells, lung cancer cell lines, mice | – | – | Promote cell proliferation and inhibit apoptosis, promote tumorigenesis in vivo | [86] |
| PAH | HOTAIR (↑) | Lung cancer | Human blood | – | – | Promote PAH-induced DNA damage | [89] |
| MALAT1 (↑) | Lung cancer | Human blood | – | – | Promote PAH-induced DNA damage | [89] |
(↑) Upregulation; (↓) Downregulation after exposure of environmental carcinogens; Anti-BPDE, Anti-benzo[a]pyrene-7,8-diol-910-epoxide; BaP, benzo[a]pyrene; PAH, Polycyclic aromatic hydrocarbon.